Siemens Healthineers: Dividend remains stable - what investors need to know!

Siemens Healthineers: Dividend remains stable - what investors need to know!

Siemens Healthineers, Deutschland - A huge amount of money is imminent! The group plans the sale of 22 million shares of its subsidiary Siemens Healthineers, which corresponds to a whopping 2 percent of the share capital. With an estimated value of around 1.2 billion euros for the Xetra closing course, these shares are to be sold to institutional investors. According to oe24.at , CFO Ralf Thomas has announced about 5 percent of the shares to Siemens Healthineers, for the financing of the 10 billion euros to support expensive purchase of the US software company Altair. Siemens currently holds 75 percent of the medical technology subsidiary.

In addition, the general meeting of Siemens Healthineers decided on February 18, 2025, a dividend of 0.95 euros per share, which remains unchanged compared to the previous year. In total, 1.06 billion euros will be distributed to the shareholders, such as finanzen.ch reported. Even if the overall release was slightly reduced compared to the previous year, the company's dividend yield remains attractive at 1.76 percent. Analysts forecast a possible increase in the dividend to 1.15 euros for 2025, which could mean a return of 2.04 percent.

The ex-dividend influence will affect the share price at short notice, since the Siemens Healthineers share closed at 57.14 euros on the day of the Annual General Meeting and the ex-dividend is now being traded. This could lead to a decline in the share price before the distributions to investors are distributed. The share has increased by 40.69 percent in the past five years, with an improved actual return (course + dividend) of 64.05 percent. All of these developments show the strong growth and stability of Siemens Healthineers in the constantly changing market of medical technology.